Skip to content

Drug interactions

Ranolazine + Rucaparib

Severity: Minor

Ranolazine and Rucaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a weak inhibitor of CYP3A4 and may modestly raise ranolazine concentrations. Ranolazine is a CYP3A substrate whose QT effect and adverse effects such as dizziness and nausea are concentration-related.

What this interaction means in plain words

Ranolazine and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ranolazine belongs to Cardiovascular; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Rucaparib weakly inhibits CYP3A4, reducing the metabolism of ranolazine.

What to do

No routine dose change is needed. Monitor for dizziness, nausea and QTc prolongation and reduce the ranolazine dose if these appear.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ranolazine and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ranolazine with Rucaparib?

MediHelp rates the interaction as minor. Ranolazine and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib is a weak inhibitor of CYP3A4 and may modestly raise ranolazine concentrations. Ranolazine is a CYP3A substrate whose QT effect and adverse effects such as dizziness and nausea are concentration-related.

How serious is the interaction between Ranolazine and Rucaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor for dizziness, nausea and QTc prolongation and reduce the ranolazine dose if these appear.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in